Stock listing

Frankfurt:0OT Ocular Therapeutix, Inc. Aktie

German listing (Frankfurt) of Ocular Therapeutix, Inc. · home listing NASDAQ:OCUL

Follow Ocular Therapeutix, Inc. into a list and get an email when it puts out news.

Share price · FWB:0OT

€6.35 EUR +0.65 (+11.4%)

Close on Oct 30, 2026

Day range
€6.35 – €6.40 EUROct 30, 2026
Ocular Therapeutix, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:OCUL · Home$6.73 USD-0.24 (-3.4%)1,881,913$6.97$7.03$6.575$6.97Close on Nov 2, 2026
Frankfurt:0OT€6.35 EUR+0.65 (+11.4%)—€6.40€6.40€6.35€5.70Close on Oct 30, 2026
Ticker
Frankfurt:0OT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Upcoming

  • Ocular Therapeutix (NASDAQ:OCUL) Q3 2026 Earnings Call

    Mon, Nov 09, 2026 · 8:00 AM ET

    Register

Replays

  • Ocular Therapeutix (NASDAQ:OCUL) Q1 2026 Earnings Call

    Tue, May 05, 2026 · 8:00 AM ET

    Watch Transcript
  • Ocular Therapeutix (NASDAQ:OCUL) Q3 2025 Earnings Call

    Tue, Nov 04, 2025 · 8:00 AM ET

    Watch Transcript
  • Ocular Therapeutix (NASDAQ:OCUL) Q2 2025 Earnings Call

    Tue, Aug 05, 2025 · 8:00 AM ET

    Watch Transcript

Latest news

All Ocular Therapeutix, Inc. news

Decks

Ocular Therapeutix, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
30 in the last 12 months · 209 in all · newest Oct 29, 2026 · oldest 2019
Calls
18 calls with a replay · 18 with a transcript · latest May 5, 2026
Decks
14 decks · latest Oct 9, 2026

Where Ocular Therapeutix, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:OCUL · Home listingNASDAQUnited StatesUSD
LS Exchange:A1180PLS ExchangeGermanyEUR
gettex:0OTgettexGermanyEUR
Tradegate:0OTTradegateGermanyEUR
Lang & Schwarz:A1180PLang & SchwarzGermanyEUR
BOATS:OCULBOATSUnited StatesUSD
BX Swiss:0OTBX SwissSwitzerlandCHF
Dusseldorf:0OTDusseldorfGermanyEUR
Frankfurt:0OT · This pageFrankfurtGermanyEUR
Hamburg:0OTHamburgGermanyEUR
Stuttgart:0OTStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Ocular Therapeutix, Inc.